Pharmaceutical composition for treating keratitis of eyes
A composition and cornea technology, applied in the field of medicine, can solve the problems of large side effects and high risks of antibiotics, and achieve the effects of convenient use and good drug safety.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0019] The characterization of experimental example 1 medicine of the present invention
[0020]
[0021] 1 H-NMR (300MHz, DMSO-d 6 ):δ[ppm]=0.86(m,2H),1.02(m,2H),1.26(t,3H),1.75(m,1H),4.02(q,2H),5.34(d,2H),6.29 (d, 1H), 6.73 (br.d, 2H), 6.84 (br.s, 2H), 8.05 (d, 1H).
experiment example 2
[0022] The effect of experimental example 2 medicine treatment eye keratitis of the present invention
[0023] model building
[0024] New Zealand white rabbits were injected with 25% urethane into the ear vein (4mL / kg), and slowly pushed in. After the corneal reflex disappeared, the eyes were given 0.4% oxybucaine hydrochloride eye drops for surface anesthesia. Reference literature for model establishment (Yu Chunzhi. Replication of Rabbit Corneal Trauma and Scar Model [J]. Journal of Fourth Military Medical University. 1982(4): 342-345.). Put the rabbit into the fixed cylinder with only the head exposed. Clamp the central part of the titanium nail rod with vascular forceps, burn the nail head on the flame spray gun for 15 seconds, cool it at room temperature for 15 seconds, pull the third eyelid of the rabbit with fixed forceps, and place the nail head in the center of the cornea of the rabbit eye. Perpendicular to the surface of the cornea of the rabbit, lightly press...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


